和黄医药再次剥离中药资产 上海医药拟斥资近10亿元实控和黄药业

第一财经
01 Jan

2025年1月1日晚间,上海医药(601607.SH)与和黄医药(00013.HK)双双公告了一桩股权交易。和黄医药将出售上海和黄药业45%的股权,上海医药将以9.95亿元收购其中的10%股权。交易完成后,上海医药将合计持有上海和黄药业60%股权,成为和黄药业的实际控制人。上海和黄药业拥有一款独家品种麝香保心丸,2023年创下营收3.49亿美元,占上海和黄药业总营收的90.43%。上海医药此项收购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10